Early retinal dopamine imbalance appears across two inherited eye disease models

by University of Eastern Finland

edited by Sadie Harley, reviewed by Robert Egan

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

A new study by researchers at the University of Eastern Finland (UEF) reports changes in the dopamine system of the retina during inherited retinal degeneration. Inherited retinal degenerations form a diverse group of genetic eye diseases that lead to vision impairment and blindness as retinal function progressively declines.

The study, published in the Journal of Neurochemistry, examined changes in the retinal dopamine system using mouse models of two forms of the disease.

Retinal dopamine levels rise in inherited retinal degeneration

Researchers found that retinal dopamine concentrations increase in the tissue even before structural degeneration begins and remain elevated as the disease progresses. The study further revealed changes in dopamine metabolism and the expression of genes related to the broader catecholamine system compared with healthy retinas.

For the first time, the study also measured and localized dopamine in the mouse retina using matrix-assisted laser desorption/ionization mass spectrometry imaging, in collaboration with researchers from Uppsala University.

Dopamine is a catecholamine neurotransmitter important for normal retinal development and function, but its role in retinal degeneration remains unclear. It acts throughout the tissue, and its effects differ among retinal cell types. Although the current study does not establish a causal link between increased dopamine levels and disease progression, the results suggest overactivation of the dopamine system during retinal degeneration and warrant further research.

Toward a treatment that works regardless of the mutation

Hundreds of different gene mutations can cause inherited retinal degeneration, making the development of gene therapies challenging from both an economic and scientific perspective. The research group led by Associate Professor Henri Leinonen at the UEF School of Pharmacy is developing a combination treatment that targets dopamine and the wider catecholamine system and could be used in different forms of retinal degeneration regardless of the underlying mutation.

The concept builds on animal studies in which compounds acting on the catecholamine system, such as alpha-2 adrenergic agonists and dopamine D2 receptor agonists, have slowed the progression of retinal degeneration.

"We know that retinal degeneration can be slowed in animal models by targeting the catecholamine system. However, we do not know why. The field is very fragmented: different laboratories have discovered promising individual compounds, but there is no unifying explanation for how they work. Our results are one piece of this puzzle. I am confident that the mechanism will be found, as long as the research continues," Leinonen said.

Next, the group will assess what the increased dopamine concentration means for disease progression: Does it accelerate degeneration, protect against it or is it simply a byproduct of other changes in the degenerating retina?

Regardless of the answer, the study shows that the catecholamine system is altered early and consistently across two genetically distinct disease models, strengthening the rationale for targeting it.

Publication details

Katri Vainionpää et al, Altered Retinal Dopamine Homeostasis in Murine Models of Retinitis Pigmentosa, Journal of Neurochemistry (2026). DOI: 10.1111/jnc.70552

Journal information: Journal of Neurochemistry

Clinical categories

Ophthalmology Provided by University of Eastern Finland Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Early retinal dopamine imbalance appears across two inherited eye disease models (2026, September 21) retrieved 22 September 2026 from https://medicalxpress.com/news/2026-09-early-retinal-dopamine-imbalance-inherited.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.